To investigate a possible correlation of PSME1 expression with clinical outcome, leiomyosarcoma patients were dichotomized into high and low PSME1 expression groups according to the sum scores of immunohistochemistry. This evidence concerns the gene PSME1 and leiomyosarcoma.